Pulmatrix, Inc. (PULM) Dividend History

Pulmatrix, Inc. (PULM) is a clinical-stage biopharmaceutical company focused on developing inhaled therapies for respiratory diseases. The company specializes in advanced dry powder and nasal spray formulations to address conditions such as respiratory infections and inflammation, leveraging its proprietary iSPERSE technology platform.

945 Concord Street, Framingham, MA, 01701
Phone: (888) 355-4440
Website: https://www.pulmatrix.com

Dividend History

Pulmatrix, Inc. currently does not pay dividends

Company News

  • Pulmatrix, Inc. (PULM) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

    Zacks Investment Research
  • Gainers ECMOHO Limited (NASDAQ: MOHO) shares rose 47% to $0.2149 in pre-market trading. Vaccitech plc (NASDAQ: VACC) shares rose 25% to $5.89 in pre-market trading. Vaccitech recently posted Q2 earnings of $0.41 per share. AIM ImmunoTech Inc. (NYSE: AIM) rose 23.8% to $0.87 in pre-market trading. AIM Immunotech recently reported commencement of Phase 2 study of Ampligen for the treatment of pancreatic cancer. Snowflake Inc. (NYSE: SNOW) rose 17.4% to $187.18 in pre-market trading after the company reported better-than-expected Q2 sales results and issued product revenue guidance. Allarity Therapeutics, Inc. (NASDAQ: ALLR) rose 16.4% to $1.42 in pre-market trading after gaining 5% on Wednesday. Ladenburg Thalmann recently downgraded Allarity Therapeutics from Buy to Neutral. FREYR Battery (NYSE: FREY) rose 14.7% to $12.14 in pre-market trading. FREYR Battery entered into strategic partnership with Hana Technology. Athersys, Inc. (NASDAQ: ATHX) rose 13.4% to $0.2029 in pre-market trading. Athersys recently reported closing of $12 million registered direct offering. ATRenew Inc. (NYSE: RERE) rose 10.6% to $3.77 in pre-market trading after jumping 19% on Wednesday. ATRenew posted Q2 loss of $0.01 per share. Pulmatrix, Inc.(NASDAQ: PULM) rose 9.6% to $5.92 in pre-market trading after jumping around 18% on Wednesday. Pulmonx recently said it sees FY22 sales of $55 million to $60 million. Autodesk, Inc. (NASDAQ:

    Benzinga
    Featured Companies: ADSK AGFY ALLR CRM JWEL LODE NTAP NVDA SNOW SPCB TCRT VSCO
Page data last updated 08/19/2025 16:43:55 UTC